IFT46
gene geneOn this page
Also known as C11orf2FLJ21827FAP32CFAP32
Summary
IFT46 (intraflagellar transport 46, HGNC:26146) is a protein-coding gene on chromosome 11q23.3, encoding Intraflagellar transport protein 46 homolog (Q9NQC8). Forms part of a complex involved in intraflagellar transport (IFT), the bi-directional movement of particles required for the assembly, maintenance and functioning of primary cilia.
Predicted to be involved in cilium assembly; intraciliary transport; and protein stabilization. Predicted to act upstream of or within smoothened signaling pathway. Located in cytoplasm. Part of intraciliary transport particle B.
Source: NCBI Gene 56912 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 68 total
- MANE Select transcript:
NM_001168618
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26146 |
| Approved symbol | IFT46 |
| Name | intraflagellar transport 46 |
| Location | 11q23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | C11orf2, FLJ21827, FAP32, CFAP32 |
| Ensembl gene | ENSG00000118096 |
| Ensembl biotype | protein_coding |
| OMIM | 620506 |
| Entrez | 56912 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 9 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000264020, ENST00000264021, ENST00000525060, ENST00000527868, ENST00000528378, ENST00000530185, ENST00000530872, ENST00000531201, ENST00000531939, ENST00000533918, ENST00000534114, ENST00000534156, ENST00000672656
RefSeq mRNA: 2 — MANE Select: NM_001168618
NM_001168618, NM_020153
CCDS: CCDS53718, CCDS8399
Canonical transcript exons
ENST00000264021 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001053493 | 118564965 | 118565061 |
| ENSE00001269870 | 118544543 | 118545011 |
| ENSE00002150985 | 118565790 | 118565931 |
| ENSE00003458344 | 118551786 | 118551852 |
| ENSE00003477024 | 118554990 | 118555083 |
| ENSE00003477432 | 118545409 | 118545494 |
| ENSE00003494040 | 118552214 | 118552335 |
| ENSE00003549761 | 118554459 | 118554587 |
| ENSE00003578770 | 118545793 | 118545853 |
| ENSE00003597191 | 118559785 | 118559864 |
| ENSE00003609498 | 118555248 | 118555322 |
| ENSE00003788341 | 118556906 | 118557045 |
Expression profiles
Bgee: expression breadth ubiquitous, 278 present calls, max score 98.51.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.9409 / max 310.2371, expressed in 1767 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 122608 | 9.4049 | 1706 |
| 122609 | 6.5360 | 1629 |
Top tissues by expression
290 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 98.51 | gold quality |
| bronchial epithelial cell | CL:0002328 | 95.15 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 95.04 | gold quality |
| bronchus | UBERON:0002185 | 94.66 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 93.61 | gold quality |
| calcaneal tendon | UBERON:0003701 | 93.36 | gold quality |
| adenohypophysis | UBERON:0002196 | 92.76 | gold quality |
| islet of Langerhans | UBERON:0000006 | 92.73 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 92.26 | gold quality |
| cerebellar cortex | UBERON:0002129 | 92.24 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 92.12 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 92.09 | gold quality |
| pituitary gland | UBERON:0000007 | 91.79 | gold quality |
| cerebellum | UBERON:0002037 | 91.23 | gold quality |
| nucleus accumbens | UBERON:0001882 | 90.95 | gold quality |
| right frontal lobe | UBERON:0002810 | 90.94 | gold quality |
| right testis | UBERON:0004534 | 90.87 | gold quality |
| caput epididymis | UBERON:0004358 | 90.78 | gold quality |
| left testis | UBERON:0004533 | 90.71 | gold quality |
| caudate nucleus | UBERON:0001873 | 90.58 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 90.58 | gold quality |
| endocervix | UBERON:0000458 | 90.57 | gold quality |
| cingulate cortex | UBERON:0003027 | 90.50 | gold quality |
| ventricular zone | UBERON:0003053 | 90.47 | gold quality |
| prefrontal cortex | UBERON:0000451 | 90.46 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.42 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 90.08 | gold quality |
| hypothalamus | UBERON:0001898 | 90.06 | gold quality |
| right adrenal gland | UBERON:0001233 | 89.93 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 89.92 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.07 |
| E-ENAD-17 | no | 350.34 |
| E-GEOD-75367 | no | 93.85 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
13 targeting IFT46, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-8080 | 99.82 | 67.52 | 1342 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-4649-3P | 99.56 | 66.90 | 1783 |
| HSA-MIR-6809-5P | 99.13 | 68.45 | 1223 |
| HSA-MIR-6868-5P | 99.06 | 65.69 | 1284 |
| HSA-MIR-6749-3P | 99.00 | 65.73 | 1443 |
| HSA-MIR-3680-5P | 98.06 | 66.20 | 394 |
| HSA-MIR-4286 | 97.20 | 64.37 | 1587 |
| HSA-MIR-2276-5P | 96.27 | 65.85 | 937 |
Literature-anchored findings (GeneRIF, showing 1)
- the ciliary protein IFT46 has a specific function in chondrocytes and is also essential for normal development of vertebrates. (PMID:17720815)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ift46 | ENSDARG00000011240 |
| mus_musculus | Ift46 | ENSMUSG00000002031 |
| rattus_norvegicus | Ift46 | ENSRNOG00000013919 |
| drosophila_melanogaster | IFT46 | FBGN0032692 |
| caenorhabditis_elegans | WBGENE00001122 |
Protein
Protein identifiers
Intraflagellar transport protein 46 homolog — Q9NQC8 (reviewed: Q9NQC8)
All UniProt accessions (8): Q9NQC8, A0A5F9ZH13, E9PIM8, E9PKW0, E9PMR8, E9PR06, E9PRT0, E9PSB9
UniProt curated annotations — full annotation on UniProt →
Function. Forms part of a complex involved in intraflagellar transport (IFT), the bi-directional movement of particles required for the assembly, maintenance and functioning of primary cilia. May play a role in chondrocyte maturation and skeletogenesis.
Subunit / interactions. Component of the IFT complex B, at least composed of IFT20, IFT22, IFT25, IFT27, IFT46, IFT52, TRAF3IP1/IFT54, IFT57, IFT74, IFT80, IFT81, and IFT88. Interacts with IFT57, IFT88 and DAW1. Interacts with IFT56. Interacts with ARL13B. Interacts with TTC25. Interacts with IFT70B.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium basal body. Cell projection. Cilium.
Similarity. Belongs to the IFT46 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NQC8-1 | 1 | yes |
| Q9NQC8-2 | 2 |
RefSeq proteins (2): NP_001162089, NP_064538 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR022088 | Intraflagellar_transp_cmplxB | Family |
Pfam: PF12317
UniProt features (12 total): sequence conflict 3, compositionally biased region 3, region of interest 2, chain 1, modified residue 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NQC8-F1 | 70.24 | 0.07 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 286
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-5620924 | Intraflagellar transport |
MSigDB gene sets: 141 (showing top):
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP, YANG_BREAST_CANCER_ESR1_LASER_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GOCC_MICROTUBULE_ORGANIZING_CENTER, EFC_Q6, UEDA_PERIFERAL_CLOCK, MARTINEZ_RB1_TARGETS_DN, KOYAMA_SEMA3B_TARGETS_UP, GOBP_CILIUM_ORGANIZATION, GOBP_PROTEIN_STABILIZATION, GOCC_CENTROSOME, GOBP_ORGANELLE_ASSEMBLY, GOBP_REGULATION_OF_PROTEIN_STABILITY, DOUGLAS_BMI1_TARGETS_DN, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
GO Biological Process (5): smoothened signaling pathway (GO:0007224), intraciliary anterograde transport (GO:0035720), intraciliary transport (GO:0042073), protein stabilization (GO:0050821), cilium assembly (GO:0060271)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (12): cytoplasm (GO:0005737), centrosome (GO:0005813), microtubule organizing center (GO:0005815), cilium (GO:0005929), intraciliary transport particle A (GO:0030991), intraciliary transport particle B (GO:0030992), motile cilium (GO:0031514), ciliary tip (GO:0097542), cytoskeleton (GO:0005856), ciliary basal body (GO:0036064), cell projection (GO:0042995), plasma membrane bounded cell projection (GO:0120025)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Assembly of the 9+0 primary cilium | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cilium | 4 |
| cellular anatomical structure | 4 |
| intraciliary transport particle | 3 |
| cilium organization | 2 |
| microtubule organizing center | 2 |
| protein-containing complex | 2 |
| cell surface receptor signaling pathway | 1 |
| intraciliary transport | 1 |
| transport along microtubule | 1 |
| regulation of protein stability | 1 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| protein localization to cilium | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| centriole | 1 |
| microtubule cytoskeleton | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| intracellular membraneless organelle | 1 |
| cell projection | 1 |
| plasma membrane region | 1 |
Protein interactions and networks
STRING
2355 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IFT46 | IFT70B | Q8N4P2 | 997 |
| IFT46 | IFT52 | Q9Y366 | 997 |
| IFT46 | IFT81 | Q8WYA0 | 996 |
| IFT46 | IFT88 | Q13099 | 996 |
| IFT46 | IFT74 | Q96LB3 | 996 |
| IFT46 | IFT27 | Q9BW83 | 995 |
| IFT46 | IFT56 | A0AVF1 | 993 |
| IFT46 | IFT25 | Q9Y547 | 992 |
| IFT46 | IFT22 | Q9H7X7 | 992 |
| IFT46 | DAW1 | Q8N136 | 983 |
| IFT46 | IFT57 | Q9NWB7 | 982 |
| IFT46 | IFT54 | Q8TDR0 | 977 |
| IFT46 | IFT20 | Q8IY31 | 965 |
| IFT46 | IFT80 | Q9P2H3 | 963 |
| IFT46 | IFT172 | Q9UG01 | 944 |
IntAct
71 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IFT56 | IFT70A | psi-mi:“MI:0914”(association) | 0.790 |
| IFT70A | IFT56 | psi-mi:“MI:0914”(association) | 0.790 |
| IFT70B | IFT56 | psi-mi:“MI:0914”(association) | 0.790 |
| IFT27 | IFT56 | psi-mi:“MI:0914”(association) | 0.690 |
| IFT25 | IFT56 | psi-mi:“MI:0914”(association) | 0.690 |
| IFT46 | IFT56 | psi-mi:“MI:0914”(association) | 0.640 |
| IFT88 | IFT56 | psi-mi:“MI:0914”(association) | 0.640 |
| IFT22 | IFT56 | psi-mi:“MI:0914”(association) | 0.640 |
| IFT57 | IFT56 | psi-mi:“MI:0914”(association) | 0.640 |
| IFT81 | NDC80 | psi-mi:“MI:0914”(association) | 0.640 |
| IFT172 | IFT56 | psi-mi:“MI:0914”(association) | 0.590 |
BioGRID (75): IFT46 (Affinity Capture-MS), IFT46 (Affinity Capture-MS), IFT46 (Affinity Capture-MS), IFT46 (Affinity Capture-MS), IFT46 (Affinity Capture-MS), IFT46 (Affinity Capture-MS), IFT46 (Proximity Label-MS), UBXN10 (Reconstituted Complex), IFT46 (Affinity Capture-MS), IFT46 (Affinity Capture-MS), IFT46 (Affinity Capture-MS), IFT46 (Affinity Capture-MS), IFT46 (Affinity Capture-MS), IFT46 (Affinity Capture-MS), IFT46 (Affinity Capture-MS)
ESM2 similar proteins: A1A4M2, A3KN28, A4VCH4, A5D8P8, A5PJA8, A6QLP7, A7E2M3, A9JRA0, O13097, O43237, O70585, O88597, P16967, P43307, P53815, P83094, Q0IHY5, Q14165, Q14457, Q1LZB4, Q4A1L3, Q4A1L4, Q4A1L5, Q4KUS2, Q4R5P6, Q4R5V2, Q5JSJ4, Q5R4X4, Q5R878, Q5RE09, Q5UCC4, Q5XI83, Q5ZKS6, Q62698, Q62768, Q68FJ8, Q68FW3, Q6DFL2, Q6GP52, Q6PDL0
Diamond homologs: A2T2X4, A7MBP4, Q0G838, Q1LZB4, Q5DHJ5, Q6AXQ9, Q9DB07, Q9NQC8
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 43 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Intraflagellar transport | 14 | 100.2× | 6e-24 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| intraciliary anterograde transport | 13 | 295.6× | 4e-29 |
| intraciliary transport | 10 | 144.0× | 4e-18 |
| negative regulation of keratinocyte proliferation | 5 | 90.0× | 1e-07 |
| keratinocyte proliferation | 5 | 74.5× | 2e-07 |
| non-motile cilium assembly | 7 | 52.1× | 3e-09 |
| smoothened signaling pathway | 9 | 41.8× | 4e-11 |
| cilium assembly | 16 | 30.2× | 3e-18 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
68 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 5 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1579 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:118545007:AAATG:A | acceptor_gain | 1.0000 |
| 11:118545008:AATG:A | acceptor_gain | 1.0000 |
| 11:118545009:ATG:A | acceptor_gain | 1.0000 |
| 11:118545010:TG:T | acceptor_gain | 1.0000 |
| 11:118545011:GC:G | acceptor_loss | 1.0000 |
| 11:118545012:C:CC | acceptor_gain | 1.0000 |
| 11:118545012:C:T | acceptor_loss | 1.0000 |
| 11:118545516:A:T | acceptor_gain | 1.0000 |
| 11:118545786:AACTC:A | donor_loss | 1.0000 |
| 11:118545787:ACT:A | donor_loss | 1.0000 |
| 11:118545788:CTC:C | donor_loss | 1.0000 |
| 11:118545789:TCA:T | donor_loss | 1.0000 |
| 11:118545790:CA:C | donor_loss | 1.0000 |
| 11:118545791:ACCAC:A | donor_loss | 1.0000 |
| 11:118545792:C:CT | donor_loss | 1.0000 |
| 11:118545792:CCA:C | donor_gain | 1.0000 |
| 11:118545849:CTTAC:C | acceptor_gain | 1.0000 |
| 11:118545854:C:CG | acceptor_loss | 1.0000 |
| 11:118552331:TGTTG:T | acceptor_gain | 1.0000 |
| 11:118552333:TTG:T | acceptor_gain | 1.0000 |
| 11:118552334:TG:T | acceptor_gain | 1.0000 |
| 11:118552336:C:CC | acceptor_gain | 1.0000 |
| 11:118554457:A:AC | donor_gain | 1.0000 |
| 11:118554458:C:CT | donor_gain | 1.0000 |
| 11:118554458:CT:C | donor_gain | 1.0000 |
| 11:118554985:TATA:T | donor_loss | 1.0000 |
| 11:118554986:ATAC:A | donor_loss | 1.0000 |
| 11:118554987:TACC:T | donor_loss | 1.0000 |
| 11:118554988:ACCT:A | donor_loss | 1.0000 |
| 11:118555082:ACC:A | acceptor_loss | 1.0000 |
AlphaMissense
2037 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:118552275:A:G | W182R | 0.999 |
| 11:118552275:A:T | W182R | 0.999 |
| 11:118554496:A:G | L149P | 0.999 |
| 11:118555012:C:A | G111V | 0.999 |
| 11:118555012:C:T | G111E | 0.999 |
| 11:118555013:C:A | G111W | 0.999 |
| 11:118555013:C:G | G111R | 0.999 |
| 11:118555013:C:T | G111R | 0.999 |
| 11:118555015:A:T | V110D | 0.999 |
| 11:118555018:G:T | A109D | 0.999 |
| 11:118555019:C:G | A109P | 0.999 |
| 11:118545434:A:G | L265P | 0.998 |
| 11:118551818:A:G | W214R | 0.998 |
| 11:118551818:A:T | W214R | 0.998 |
| 11:118552273:C:A | W182C | 0.998 |
| 11:118552273:C:G | W182C | 0.998 |
| 11:118554553:C:T | G130D | 0.998 |
| 11:118554554:C:G | G130R | 0.998 |
| 11:118554586:A:T | V119D | 0.997 |
| 11:118555038:G:C | F102L | 0.997 |
| 11:118555038:G:T | F102L | 0.997 |
| 11:118555040:A:G | F102L | 0.997 |
| 11:118555266:A:G | L81P | 0.997 |
| 11:118551829:A:G | L210P | 0.996 |
| 11:118552274:C:G | W182S | 0.996 |
| 11:118554490:A:G | L151S | 0.996 |
| 11:118554502:A:G | L147P | 0.996 |
| 11:118554553:C:A | G130V | 0.996 |
| 11:118554990:C:A | K118N | 0.996 |
| 11:118554990:C:G | K118N | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000130676 (11:118553382 G>A), RS1000219480 (11:118550217 G>A), RS1000243255 (11:118556650 C>T), RS1000289841 (11:118550010 G>A), RS1000373287 (11:118564677 A>G), RS1000375857 (11:118570493 C>A,G), RS1000823802 (11:118562819 A>G), RS1000993213 (11:118575183 T>A), RS1001315245 (11:118565154 C>T), RS1001339403 (11:118571540 C>T), RS1001388557 (11:118564781 G>A), RS1001456622 (11:118569019 G>A), RS1001545999 (11:118550860 C>G), RS1001578541 (11:118544165 C>G), RS1001620372 (11:118556759 T>C)
Disease associations
OMIM: gene MIM:620506 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010204_64 | Low density lipoprotein cholesterol levels | 9.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004611 | low density lipoprotein cholesterol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases abundance, increases expression, affects expression | 2 |
| Valproic Acid | affects expression, increases expression | 2 |
| Cadmium Chloride | decreases expression | 2 |
| bisphenol F | affects cotreatment, decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| beta-lapachone | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| manganese chloride | decreases expression, increases abundance | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| corosolic acid | increases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Manganese | decreases expression, increases abundance | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.